Detalhe da pesquisa
1.
Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
N Engl J Med
; 386(18): 1700-1711, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353960
2.
Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients.
J Infect Dis
; 229(1): 54-58, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380166
3.
The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.
PLoS Med
; 21(1): e1004325, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215160
4.
Mpox in people with advanced HIV infection: a global case series.
Lancet
; 401(10380): 939-949, 2023 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828001
5.
A Growing Number of Men Who Have Sex With Men Aging With HIV (20212031): A Comparison of Two Microsimulation Models.
J Infect Dis
; 227(3): 412-422, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478076
6.
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial.
J Infect Dis
; 227(11): 1266-1273, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722044
7.
Hospital Readmissions Among Persons With Human Immunodeficiency Virus in the United States and Canada, 2005-2018: A Collaboration of Cohort Studies.
J Infect Dis
; 228(12): 1699-1708, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697938
8.
Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample.
Clin Infect Dis
; 77(2): 237-241, 2023 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36987595
9.
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
Clin Infect Dis
; 76(10): 1727-1734, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861341
10.
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019.
Clin Infect Dis
; 76(11): 2018-2024, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36740590
11.
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.
Clin Infect Dis
; 76(3): e477-e486, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579509
12.
Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine.
Am J Epidemiol
; 192(8): 1341-1349, 2023 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922393
13.
Design and Implementation of the All of Us Research Program COVID-19 Participant Experience (COPE) Survey.
Am J Epidemiol
; 192(6): 972-986, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799620
14.
Absence of pathogenic viruses in COVID-19 convalescent plasma.
Transfusion
; 63(1): 23-29, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36268708
15.
Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US.
JAMA
; 329(1): 52-62, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594946
16.
Discrimination and Calibration of the Veterans Aging Cohort Study Index 2.0 for Predicting Mortality Among People With Human Immunodeficiency Virus in North America.
Clin Infect Dis
; 75(2): 297-304, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34609485
17.
Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020.
Clin Infect Dis
; 74(4): 584-590, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34128970
18.
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?
Transfusion
; 62(5): 933-941, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352362
19.
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design.
Pharmacoepidemiol Drug Saf
; 31(2): 214-224, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34729853
20.
Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years.
J Infect Dis
; 224(4): 657-666, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398239